e-therapeutics showcase

e-therapeutics showcase

e-therapeutics — 2 videos in collection

More on this equity

e-therapeutics is a UK biotech company using proprietary computational biology and RNAi platforms to discover novel disease targets and therapies. The company is specifically focused on leveraging its expertise to design treatments for hepatocyte-associated disease indications (not restricted to diseases in the liver) with untapped, novel targets, providing scope for new treatments to have a unique offering.

In partnership with Curation Connect, we are pleased to share the e-therapeutics showcase, which curates a range of different Edison, company and industry material for investors to learn more about this stock.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free